Silencing of CD44 Expression in Prostate Cancer by Hypermethylation of the CD44 Promoter Region
- 1 August 2000
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 80 (8) , 1291-1298
- https://doi.org/10.1038/labinvest.3780137
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- CpG methylation, chromatin structure and gene silencing---a three-way connectionThe EMBO Journal, 1998
- How does DNA methylation repress transcription?Trends in Genetics, 1997
- CD44: Structure, Function and Association with the Malignant ProcessPublished by Elsevier ,1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- CD44 as a marker in human cancersCurrent Opinion in Oncology, 1997
- Prostate-specific antigen: its clinical use and application in screening for prostate cancerScandinavian Journal of Clinical and Laboratory Investigation, 1995
- Hyaluronate receptors: key players in growth, differentiation, migration and tumor progressionCurrent Opinion in Cell Biology, 1994
- Splicing choice from ten variant exons establishes CD44 variabilityNucleic Acids Research, 1993
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated.Genes & Development, 1988